Did You Know...
...that one person who claimed to be the inventor of the television is Russian emigre Vladimir Zworykin? In 1929 David Sarnoff, founder of RCA, asked Zworykin what it would take to develop TV for commercial use. He said: a year and a half and $100,000. In reality, it took 20 years and $50 million! Before his death in 1982 at the age of 92, Zworykin said of his invention: "The technique is wonderful. It is beyond my expectations. But the programs! I would never let my children even come close to this thing."
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7759625 | Systems and methods for multimodal imaging using a volumetric representation of an object The invention relates to imaging systems that include a coded aperture detection system and an optical detection system. The coded aperture detection system is configured to detect radiation emitted by a radionuclide present within an object and to provide a first d... | 07/20/2010 |
| 6531156 | Aqueous solven encapsulation method, apparatus and microcapsules The present invention relates to microcapsules comprising a wall and an aqueous core comprising various active agents, and prepared by the interfacial reaction in aqueous medium of Lewis acid and base wall-forming reactants.... | 03/11/2003 |
| 6290968 | Rotavirus reassortant vaccine The present invention provides novel rotavirus reassortants, vaccines employing the novel reassortants and methods for their preparation and administration. One such reassortant contains the gene encoding the v.p.7 neutralization antigen of a human rotavi... | 09/18/2001 |
| 6093392 | Methods and compositions for use in gene therapy for treatment of hemophilia The invention includes a composition comprising a recombinant adeno-associated viral vector comprising at least two adeno-associated virus inverted terminal repeats, a promoter/regulatory sequence, isolated DNA encoding Factor IX and accompanying 5' and 3... | 07/25/2000 |
| 6077083 | Doll for instruction of sickle cell disease clinical observations A medical teaching doll is provided with devices for simulating the differences between normal organs, and organs which are physically altered by sickle cell or other disease. The devices simulate the normal and diseased conditions so that the differences... | 06/20/2000 |
| 5985547 | Detection of a mutation in the HLA-DMଲ gene in an immunocompromised patient The identification of a mutation in the HLA-DMB locus in antigen presenting cells defective in presenting antigen is described. Methods of diagnosis and treatment of immunocompromised individuals and compositions and methods of treatment for patients suff... | 11/16/1999 |
| 5948681 | Non-viral vehicles for use in gene transfer The invention relates to a compositions and methods for transfection of cells, particularly airway epithelial cells, with DNA complexed to polylysine substituted with glycosyl residues. The invention also relates to methods of treating humans having respi... | 09/07/1999 |
| 5935783 | Genes mapping in the digeorge and velocardiofacial syndrome minimal critical region Transcription units encoded in the minimal DGS/VCFS critical region, primer pairs effective for amplifying said transcripts in a genomic DNA sample for the preparation of probes for detecting genetic deletions/mutations in the minimal DGS/VCFS critical re... | 08/10/1999 |
| 5756105 | Opacity associated proteins, DNA encoding the same, and methods of use thereof Opacity associated proteins and DNA encoding the same are provided by the present invention. Opacity associated proteins are membrane proteins of H. influenzae which are useful as immunogens in vaccines against infection by H. influenzae. Recombinant cell... | 05/26/1998 |
| 5714666 | Measurement of intracellular calcium using bioluminescent apoaequorin expressed in mammalian cells Mammalian cells which express apoaequorin and a receptor involved in the modulation of intracellular calcium are provided by the present invention. Transgenic mice in which neuronal cells express aequorin are also provided. Methods of use are provided.... | 02/03/1998 |
| 5676945 | Human leucine-zipper protein kinase and methods of use A novel protein kinase, leucine-zipper protein kinase, 668 amino acids in length is provided by the present invention. This protein kinase is localized to the human brain. Nucleic acid sequences encoding the protein kinase are also provided.... | 10/14/1997 |
| 5650278 | Compositions and diagnostic kits for identifying alveolar rhabdomyosarcoma Methods of determining whether a tumor is an alveolar rhabdomyosarcoma tumor by detecting the presence of a DNA sequence of a chimeric gene that is generated by translocation of a portion of human chromosome 2 and a portion of human chromosome 13 are disc... | 07/22/1997 |
| 5601820 | Compositions and methods of making and using human full length TRK-B The amino acid sequence of the full length version of the human neurotrophic factor receptor TRK B and a nucleotide sequence encoding it are disclosed. Transformed host cells and transgenic animals containing nucleic acid molecules encoding full length hu... | 02/11/1997 |
| 5554523 | Nucleic acid sequences encoding human leucine-zipper protein-kinase A novel protein kinase, leucine-zipper protein kinase, 668 amino acids in length is provided by the present invention. This protein kinase is localized to the human brain. Nucleic acid sequences encoding the protein kinase are also provided.... | 09/10/1996 |
| 5472944 | Suppression of megakaryocytopoiesis by neutrophil activating peptide-2 Neutrophil activating peptide-2 or analog thereof is administered to a mammal to achieve therapeutic reduction of the number of circulating platelets. The peptide is useful in treating essential thrombocythemia and reactive thrombocytosis.... | 12/05/1995 |
| 5449609 | Methods for screening for neurotoxicity using a clonal human teratocarcinoma cell line Methods for screening for excitotoxic effects of an agent on neurons of the central nervous system are provided by the present invention.... | 09/12/1995 |
| 5304496 | Biological regulation of mineralization An aspartic acid rich protein isolated from human urine, as well as proteins having substantial homology thereto and active portions of the foregoing are effective modulators of mineralization in mammals. These proteins and peptides are useful as therapeu... | 04/19/1994 |
